Shijiazhuang Yiling Pharmaceutical Co Ltd Capital Reinvestment Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd capital reinvestment ratio. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥446.51 Million) in capital expenditures (CN¥84.38 Million). Check how aggressively does Shijiazhuang Yiling Pharmaceutical Co Lt reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Capital reinvestment ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. This chart tracks Shijiazhuang Yiling Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 17 annual periods. Also explore Shijiazhuang Yiling Pharmaceutical Co Lt equity growth rate to track the company's year-over-year net asset growth rate.
Shijiazhuang Yiling Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2008–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd capital reinvestment ratio by year from 2008 to 2025. For the full cash flow conversion analysis, see Shijiazhuang Yiling Pharmaceutical Co Lt cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | CN¥1.78 Billion | CN¥245.62 Million | ▼ -70.9% |
| 2024 | 0.48x | CN¥611.01 Million | CN¥290.39 Million | ▼ -76.2% |
| 2023 | 2.00x | CN¥155.46 Million | CN¥310.83 Million | ▲ +3159.0% |
| 2022 | 0.06x | CN¥3.49 Billion | CN¥213.98 Million | ▼ -95.2% |
| 2021 | 1.27x | CN¥528.69 Million | CN¥673.56 Million | ▲ +76.5% |
| 2020 | 0.72x | CN¥1.59 Billion | CN¥1.14 Billion | ▼ -89.1% |
| 2019 | 6.59x | CN¥68.93 Million | CN¥454.43 Million | ▲ +154.8% |
| 2018 | 2.59x | CN¥72.37 Million | CN¥187.23 Million | ▲ +64.5% |
| 2017 | 1.57x | CN¥114.65 Million | CN¥180.35 Million | ▲ +170.5% |
| 2016 | 0.58x | CN¥641.45 Million | CN¥373.03 Million | ▼ -84.0% |
| 2015 | 3.63x | CN¥131.88 Million | CN¥478.43 Million | ▼ -14.7% |
| 2014 | 4.25x | CN¥105.90 Million | CN¥450.19 Million | ▼ -42.6% |
| 2013 | 7.41x | CN¥55.32 Million | CN¥409.83 Million | ▲ +75.0% |
| 2012 | 4.23x | CN¥70.13 Million | CN¥296.89 Million | ▲ +345.2% |
| 2010 | 0.95x | CN¥299.72 Million | CN¥285.02 Million | ▲ +43.7% |
| 2009 | 0.66x | CN¥318.21 Million | CN¥210.57 Million | ▲ +8.4% |
| 2008 | 0.61x | CN¥210.18 Million | CN¥128.27 Million | — |